154 related articles for article (PubMed ID: 10761803)
1. Intensity of antianginal therapy in patients referred for coronary angiography: a comparison of fee-for-service and health maintenance organization therapeutic strategies.
Samuels BA; Diamond GA; Mahrer PR; Denton TA
Clin Cardiol; 2000 Mar; 23(3):165-70. PubMed ID: 10761803
[TBL] [Abstract][Full Text] [Related]
2. Differences in discharge medication after acute myocardial infarction in patients with HMO and fee-for-service medical insurance.
McCormick D; Gurwitz JH; Savageau J; Yarzebski J; Gore JM; Goldberg RJ
J Gen Intern Med; 1999 Feb; 14(2):73-81. PubMed ID: 10051777
[TBL] [Abstract][Full Text] [Related]
3. Timeliness and quality of care for elderly patients with acute myocardial infarction under health maintenance organization vs fee-for-service insurance.
Soumerai SB; McLaughlin TJ; Gurwitz JH; Pearson S; Christiansen CL; Borbas C; Morris N; McLaughlin B; Gao X; Ross-Degnan D
Arch Intern Med; 1999 Sep; 159(17):2013-20. PubMed ID: 10510986
[TBL] [Abstract][Full Text] [Related]
4. Is referral source a risk factor for coronary surgery? Health maintenance organization versus fee-for-service system.
Starr A; Furnary AP; Grunkemeier GL; He GW; Ahmad A
J Thorac Cardiovasc Surg; 1996 Apr; 111(4):708-16; discussion 716-7. PubMed ID: 8614131
[TBL] [Abstract][Full Text] [Related]
5. Medical therapy after successful percutaneous coronary revascularization.
Hasdai D; Lerman A; Grill DE; Rihal CS; Holmes DR
Ann Intern Med; 1999 Jan; 130(2):108-15. PubMed ID: 10068356
[TBL] [Abstract][Full Text] [Related]
6. Variations in patterns of care and outcomes after acute myocardial infarction for Medicare beneficiaries in fee-for-service and HMO settings.
Luft HS
Health Serv Res; 2003 Aug; 38(4):1065-79. PubMed ID: 12968817
[TBL] [Abstract][Full Text] [Related]
7. Management and outcomes of non-ST elevation acute coronary syndromes in relation to previous use of antianginal therapies (from the Canadian Global Registry of Acute Coronary Events [GRACE] and Canadian Registry of Acute Coronary Events [CANRACE]).
Kang JS; Goodman SG; Yan RT; Lopez-Sendon J; Pesant Y; Graham JJ; Fitchett D; Wong GC; Rose BF; Spencer FA; Yan AT;
Am J Cardiol; 2013 Jul; 112(1):51-6. PubMed ID: 23582629
[TBL] [Abstract][Full Text] [Related]
8. Stage at diagnosis and treatment patterns among older women with breast cancer: an HMO and fee-for-service comparison.
Riley GF; Potosky AL; Klabunde CN; Warren JL; Ballard-Barbash R
JAMA; 1999 Feb; 281(8):720-6. PubMed ID: 10052442
[TBL] [Abstract][Full Text] [Related]
9. Differences in 4-year health outcomes for elderly and poor, chronically ill patients treated in HMO and fee-for-service systems. Results from the Medical Outcomes Study.
Ware JE; Bayliss MS; Rogers WH; Kosinski M; Tarlov AR
JAMA; 1996 Oct; 276(13):1039-47. PubMed ID: 8847764
[TBL] [Abstract][Full Text] [Related]
10. Concomitant use of nitrates, calcium channel blockers, and beta blockers for optimal antianginal therapy.
Cohn PF
Clin Cardiol; 1994 Aug; 17(8):415-21. PubMed ID: 7955587
[TBL] [Abstract][Full Text] [Related]
11. [Systematic review on the short-term efficacy and safety of nicorandil for stable angina pectoris in comparison with those of β-blockers, nitrates and calcium antagonists].
Hanai Y; Mita M; Hishinuma S; Shoji M
Yakugaku Zasshi; 2010 Nov; 130(11):1549-63. PubMed ID: 21048416
[TBL] [Abstract][Full Text] [Related]
12. Meta-analysis of trials comparing beta-blockers, calcium antagonists, and nitrates for stable angina.
Heidenreich PA; McDonald KM; Hastie T; Fadel B; Hagan V; Lee BK; Hlatky MA
JAMA; 1999 May; 281(20):1927-36. PubMed ID: 10349897
[TBL] [Abstract][Full Text] [Related]
13. Resource utilization in treatment of acute myocardial infarction: staff-model health maintenance organization versus fee-for-service hospitals. The MITI Investigators. Myocardial Infarction Triage and Intervention.
Every NR; Fihn SD; Maynard C; Martin JS; Weaver WD
J Am Coll Cardiol; 1995 Aug; 26(2):401-6. PubMed ID: 7608441
[TBL] [Abstract][Full Text] [Related]
14. Profile of an ideal antianginal agent.
Lazar EJ; Frishman WH
Drugs; 1989; 38 Suppl 2():1-8. PubMed ID: 2575973
[TBL] [Abstract][Full Text] [Related]
15. Anti-anginal drugs: calcium channel blockers, beta-adrenergic blockers and nitrates.
Chourashy BK
J Indian Med Assoc; 1988 Oct; 86(10):274-6. PubMed ID: 2907344
[No Abstract] [Full Text] [Related]
16. Quality of ambulatory care after myocardial infarction among Medicare patients by type of insurance and region.
Seddon ME; Ayanian JZ; Landrum MB; Cleary PD; Peterson EA; Gahart MT; McNeil BJ
Am J Med; 2001 Jul; 111(1):24-32. PubMed ID: 11448657
[TBL] [Abstract][Full Text] [Related]
17. Influence of payor on use of invasive cardiac procedures and patient outcome after myocardial infarction in the United States. Participants in the National Registry of Myocardial Infarction.
Sada MJ; French WJ; Carlisle DM; Chandra NC; Gore JM; Rogers WJ
J Am Coll Cardiol; 1998 Jun; 31(7):1474-80. PubMed ID: 9626822
[TBL] [Abstract][Full Text] [Related]
18. Antianginal Agents for the Management of Stable Ischemic Heart Disease: A Review.
Mody P; Sidhu MS; Brilakis ES; Sacco JD; Banerjee S; Boden WE
Cardiol Rev; 2016; 24(4):177-89. PubMed ID: 26274534
[TBL] [Abstract][Full Text] [Related]
19. Medical management of angina: nitrates, beta blockers, calcium channel blockers.
Goosby E; Goldschlager N
Postgrad Med; 1982 Sep; 72(3):50-2, 55-9, 62-3 passim. PubMed ID: 6126868
[No Abstract] [Full Text] [Related]
20. Hypothyroidism complicated by angina pectoris: therapeutic approaches.
Ellyin FM; Kumar Y; Somberg JC
J Clin Pharmacol; 1992 Sep; 32(9):843-7. PubMed ID: 1358924
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
